|
|
Volume 5, Issue 6, June 1998, in PDF
|
   |
Article 88: Eye On: Breast Cancer
- CenterWatch editorial staff review new treatments in research for breast cancer and identify 39 therapies in clinical development.
Article 89: SMOs Chalking Up Mixed Results
- CenterWatch editors show that most activity in the SMO market is being driven by only a handful of companies. Many SMOs are not performing well financially.
- Clinical Studies, Affiliated Research Centers, and Hill Top Research are considered the top three SMOs while MDS Harris, Protocare, and Clinical reSearchNet are making news as up-and-comers.
Article 90: European Sites Rate Sponsors
- CenterWatch presents the results of its first survey of European sites.
- Sixty percent of the 300 European sites surveyed rate Eli Lilly best in overall performance.
- Respondents to the survey said that top-rated sponsors use of local offices and on-staff CRAs are key in maintaining successful relationships with European investigators.
Price: $59.00
|
|
|
